Description
Tesamorelin + Ipamorelin | GHRH Analog and Selective GHRP – Research Blend
This research preparation combines Tesamorelin, a stabilised analog of growth hormone-releasing hormone, with Ipamorelin, a selective pentapeptide growth hormone secretagogue active at the ghrelin receptor.
The two components act on distinct receptor pathways, Tesamorelin at the GHRH receptor and Ipamorelin at GHS-R1a. A combined preparation allows pathway interaction and comparative secretagogue signalling to be examined within a single model system.
Common research applications: growth hormone secretagogue research, GPCR signalling studies, and comparative peptide interaction research.
Specifications
| Compound | Tesamorelin + Ipamorelin |
|---|---|
| Composition | 10mg Tesamorelin, 5mg Ipamorelin |
| Quantity | 10mg Tesamorelin plus 5mg Ipamorelin per vial |
| Purity | 99%+ (HPLC/MS) |
| Form | Lyophilized powder |
| Storage | Store lyophilized at minus 20 C, protect from light. |
Frequently Asked Questions
What is Tesamorelin + Ipamorelin?
It is a combined research preparation containing 10mg Tesamorelin, a GHRH analog, and 5mg Ipamorelin, a selective growth hormone secretagogue.
What is Tesamorelin + Ipamorelin studied for?
The blend is used to study interaction between the GHRH receptor and GHS-R1a signalling pathways. All work is laboratory research only.
What purity is Tesamorelin 10mg + Ipamorelin 5mg supplied at?
It is supplied as lyophilized powder at 99%+ purity, verified by independent HPLC and mass spectrometry testing.
For Research Use Only
This material is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, diagnosis, treatment, or consumption. By purchasing, the buyer confirms they are a qualified researcher and agrees to handle this product in compliance with all applicable regulations.
📚 Research guide: Read our Sermorelin vs Ipamorelin vs CJC-1295: GHRH and Ghrelin Receptor Routes Compared
Research guide: Tesamorelin research overview · Ipamorelin and CJC-1295 research overview
Reviews
There are no reviews yet.